De novo gene mutations highlight patterns of genetic and neural complexity in schizophrenia

Xu, Bin, Ionita-Laza, Iuliana, Roos, J Louw, Boone, Braden, Woodrick, Scarlet, Sun, Yan, Levy, Shawn, Gogos, Joseph A, Karayiorgou, Maria·2012·Nature Genetics
DOI 10.1038/ng.2446

Cited by (442)

Items 101–200 of 442

  1. A Matter of Balance: Role of Neurexin and Neuroligin at the Synapse
    Marie‐Louise Bang, Sylwia Owczarek · 2013 · Neurochemical Research
  2. Molecular genetic gene–environment studies using candidate genes in schizophrenia: A systematic review
    Gemma Modinos, Conrad Osamede Iyegbe, Diana Pinto Prata, Margarita Rivera, Matthew J. Kempton, Lucia Valmaggia, Pak Chung Sham, Jim van Os, Philip K. McGuire · 2013 · Schizophrenia Research
  3. Genome-wide analysis of attention deficit hyperactivity disorder in Norway
    Zayats, Tetyana, Athanasiu, Lavinia, Sonderby, Ida, Djurovic, Srdjan, Westlye, Lars T., Tamnes, Christian K., Fladby, Tormod, Aase, Heidi, Zeiner, Pål, Reichborn-Kjennerud, Ted et al. · 2015 · PLoS ONE
  4. Scan statistic-based analysis of exome sequencing data identifies FAN1 at 15q13.3 as a susceptibility gene for schizophrenia and autism
    Iuliana Ionita‐Laza, Bin Xu, Vlad Makarov, Joseph D. Buxbaum, Johannes Lodewikus Roos, Joseph A. Gogos, Maria Karayiorgou · 2013 · Proceedings of the National Academy of Sciences
  5. MACF1 Mutations Encoding Highly Conserved Zinc-Binding Residues of the GAR Domain Cause Defects in Neuronal Migration and Axon Guidance
    William B. Dobyns, Kimberly A. Aldinger, Gisele E. Ishak, Ghayda Mirzaa, Andrew E. Timms, Megan E. Grout, Marjolein H. G. Dremmen, Rachel Schot, Laura V. Vandervore, Marjon A. van Slegtenhorst et al. · 2018 · The American Journal of Human Genetics
  6. Animal models of gene–environment interaction in schizophrenia: A dimensional perspective
    Yavuz Ayhan, Ross McFarland, Mikhail V. Pletnikov · 2015 · Progress in Neurobiology
  7. Interpreting the role of de novo protein-coding mutations in neuropsychiatric disease
    Gratten, Jacob, Visscher, Peter M, Mowry, Bryan J, Wray, Naomi R · 2013 · Nature Genetics
  8. Recent Advances in the Genetics of Schizophrenia
    Dimitrios Avramopoulos · 2018 · Complex Psychiatry
  9. Long Non-Coding RNAs in Multifactorial Diseases: Another Layer of Complexity
    Gabriel Adelman Cipolla, Jaqueline Carvalho de Oliveira, Amanda Salviano‐Silva, Sara Cristina Lobo‐Alves, Débora S. Lemos, Luana Oliveira, Tayana Schultz Jucoski, Carolina Mathias, Gabrielle Araújo Pedroso, Érika Pereira Zambalde et al. · 2018 · Non-Coding RNA
  10. De novo mutations from whole exome sequencing in neurodevelopmental and psychiatric disorders: From discovery to application
    Wang, Weidi, Corominas, Roser, Lin, Guan Ning · 2019 · Frontiers in Genetics
  11. Schizophrenia miR-137 Locus Risk Genotype Is Associated with Dorsolateral Prefrontal Cortex Hyperactivation
    Theo G.M. van Erp, Ilaria Guella, Marquis P. Vawter, Jessica A. Turner, Gregory G. Brown, Gregory McCarthy, Douglas N. Greve, Gary H. Glover, Vince D. Calhoun, Kelvin O. Lim et al. · 2013 · Biological Psychiatry
  12. Increased burden ofde novopredicted deleterious variants in complex congenital diaphragmatic hernia
    Lan Yu, Ashley Sawle, Julia Wynn, Guðrún Aspelund, Charles J.H. Stolar, Marc S. Arkovitz, Douglas A. Potoka, Kenneth S. Azarow, George B. Mychaliska, Yufeng Shen et al. · 2015 · Human Molecular Genetics
  13. Genome-wide analysis of differential RNA editing in epilepsy
    Prashant Kumar Srivastava, Marta Bagnati, Andrée Delahaye‐Duriez, Jeong‐Hun Ko, Maxime Rotival, Sarah R. Langley, Kirill Shkura, Manuela Mazzuferi, Bénédicte Danis, Jonathan M. van Eyll et al. · 2017 · Genome Research
  14. De Novo Truncating Mutations in the Last and Penultimate Exons of PPM1D Cause an Intellectual Disability Syndrome
    Sandra Jansen, Sinje Geuer, Rolph Pfundt, Rachel Brough, Priyanka Ghongane, Johanna C. Herkert, Elysa J. Marco, Marjolein H. Willemsen, Tjitske Kleefstra, Mark Hannibal et al. · 2017 · The American Journal of Human Genetics
  15. Genetics of schizophrenia
    Elliott Rees, Michael C. O’Donovan, Michael John Owen · 2014 · Current Opinion in Behavioral Sciences
  16. Serotonin-related pathways and developmental plasticity: relevance for psychiatric disorders
    Alexandre G. Dayer · 2014 · Dialogues in Clinical Neuroscience
  17. Neuroanatomical phenotypes in a mouse model of the 22q11.2 microdeletion
    Jacob Ellegood, Sander Markx, Jason P. Lerch, Patrick E. Steadman, C Genç, Frank A. Provenzano, Steven A. Kushner, R. Mark Henkelman, Maria Karayiorgou, Joseph A. Gogos · 2013 · Molecular Psychiatry
  18. The Role of Brain Microvascular Endothelial Cell and Blood-Brain Barrier Dysfunction in Schizophrenia
    Sovannarath Pong, Rakesh Karmacharya, Marianna Sofman, Jeffrey R. Bishop, Paulo L. Lizano · 2020 · Complex Psychiatry
  19. Neurodevelopmental disease-associated de novo mutations and rare sequence variants affect TRIO GDP/GTP exchange factor activity
    Sara Marie Katrancha, Yi Wu, Min‐Sheng Zhu, Betty A. Eipper, Anthony J. Koleske, Richard E. Mains · 2017 · Human Molecular Genetics
  20. Candidate CSPG4 mutations and induced pluripotent stem cell modeling implicate oligodendrocyte progenitor cell dysfunction in familial schizophrenia
    Femke M. S. de Vrij, Christian G. Bouwkamp, Nilhan Gunhanlar, Guy Shpak, Bas Lendemeijer, Maarouf Baghdadi, Shreekara Gopalakrishna, Mehrnaz Ghazvini, Tracy M.W.Y. Li, Marialuisa Quadri et al. · 2018 · Molecular Psychiatry
  21. Whole genome/exome sequencing in mood and psychotic disorders
    Tadafumi Kato · 2014 · Psychiatry and Clinical Neurosciences
  22. Copy Number Variable MicroRNAs in Schizophrenia and Their Neurodevelopmental Gene Targets
    W. David Warnica, Daniele Merico, Gregory Costain, Simon E. Alfred, John Wei, Christian R. Marshall, Stephen W. Scherer, Anne S. Bassett · 2014 · Biological Psychiatry
  23. Genetics of schizophrenia: A consensus paper of the WFSBP Task Force on Genetics
    Ina Giegling, Ladislav Hosák, Rainald Mößner, Alessandro Serretti, Frank Bellivier, Stephan J. Claes, David Andrew Collier, Alejo Corrales, Lynn E. DeLisi, Carla Gallo et al. · 2017 · The World Journal of Biological Psychiatry
  24. Chronic LSD alters gene expression profiles in the mPFC relevant to schizophrenia
    Martin, David A., Marona-Lewicka, Danuta, Nichols, David E., Nichols, Charles D. · 2014 · Neuropharmacology
  25. Gene4Denovo: an integrated database and analytic platform for de novo mutations in humans
    Guihu Zhao, Kuokuo Li, Bin Li, Zheng Wang, Zhenghuan Fang, Xiaomeng Wang, Yi Zhang, Tengfei Luo, Qiao Zhou, Lin Wang et al. · 2019 · Nucleic Acids Research
  26. The role of genetics and genomics in clinical psychiatry
    Margret R. Hoehe, Deborah J. Morris-Rosendahl · 2018 · Dialogues in Clinical Neuroscience
  27. A Potential Contributory Role for Ciliary Dysfunction in the 16p11.2 600 kb BP4-BP5 Pathology
    Eugenia Migliavacca, Christelle Golzio, Katrin Männik, Ian Blumenthal, Edwin C. T. Oh, Louise Harewood, Jack A. Kosmicki, Maria Nicla Loviglio, Giuliana Giannuzzi, Loyse Hippolyte et al. · 2015 · The American Journal of Human Genetics
  28. Genetic analysis of schizophrenia and bipolar disorder reveals polygenicity but also suggests new directions for molecular interrogation
    Benjamin M. Neale, Pamela B. Sklar · 2014 · Current Opinion in Neurobiology
  29. Transcriptional consequences of schizophrenia candidate miR-137 manipulation in human neural progenitor cells
    Matthew Hill, Jacek G. Donocik, Rosamond A. Nuamah, Charles A. Mein, Ricardo Sáinz‐Fuertes, Nicholas J. Bray · 2014 · Schizophrenia Research
  30. Toward a Deeper Understanding of the Genetics of Bipolar Disorder
    Berit Kerner · 2015 · Frontiers in Psychiatry
  31. MicroRNAs and psychiatric disorders: From aetiology to treatment
    Alessia Luoni, Marco Andrea Riva · 2016 · Pharmacology & Therapeutics
  32. Alteration of Neuronal Excitability and Short-Term Synaptic Plasticity in the Prefrontal Cortex of a Mouse Model of Mental Illness
    Gregg W. Crabtree, Ziyi Sun, Mirna Kvajo, Jantine A.C. Broek, Karine Fénelon, Heather McKellar, Lan Xiao, Bin Xu, Sabine Bahn, James M. O’Donnell et al. · 2017 · Journal of Neuroscience
  33. The molecular pathology of schizophrenia: an overview of existing knowledge and new directions for future research
    Takumi Nakamura, Atsushi Takata · 2023 · Molecular Psychiatry
  34. Genetics of psychiatric disorders in the GWAS era: an update on schizophrenia
    Sibylle G. Schwab, Dieter B. Wildenauer · 2013 · European Archives of Psychiatry and Clinical Neuroscience
  35. Genetics of Schizophrenia
    Escudero, Irene, Johnstone, Mandy · 2014 · Current Psychiatry Reports
  36. Exome arrays capture polygenic rare variant contributions to schizophrenia
    Richards, A. L., Leonenko, G., Walters, J. T., Kavanagh, D. H., Rees, E. G., Evans, A., Chambert, K. D., Moran, J. L., Goldstein, J., Neale, B. M. et al. · 2016 · Human Molecular Genetics
  37. Synaptic and Gene Regulatory Mechanisms in Schizophrenia, Autism, and 22q11.2 Copy Number Variant–Mediated Risk for Neuropsychiatric Disorders
    Jennifer K. Forsyth, Daniel C. Nachun, Michael J. Gandal, Daniel H. Geschwind, Ariana Anderson, Giovanni Coppola, Carrie E. Bearden · 2019 · Biological Psychiatry
  38. Comprehensive analysis of schizophrenia-associated loci highlights ion channel pathways and biologically plausible candidate causal genes
    Tune H. Pers, Pascal N. Timshel, Stephan Ripke, Patrick F. Sullivan, Michael C. O’Donovan, Lude Franke, Joel N. Hirschhorn · 2016 · Human Molecular Genetics
  39. A genotype-first approach identifies an intellectual disability-overweight syndrome caused by PHIP haploinsufficiency
    Sandra Jansen, Alexander Hoischen, Bradley P. Coe, Gemma L. Carvill, Hilde Van Esch, Daniëlle G.M. Bosch, Ulla A. Andersen, Carl A. Baker, Marijke Bauters, Raphael Bernier et al. · 2017 · European Journal of Human Genetics
  40. Brain-trait-associated variants impact cell-type-specific gene regulation during neurogenesis
    Nil Aygün, Angela L. Elwell, Dan Liang, Michael J. Lafferty, Kerry E. Cheek, Kenan P. Courtney, Jessica T. Mory, Ellie Hadden-Ford, Oleh Krupa, Luis de la Torre-Ubieta et al. · 2021 · The American Journal of Human Genetics
  41. A review of study designs and statistical methods for genomic epidemiology studies using next generation sequencing
    Qian Wang, Qiongshi Lu, Hongyu Zhao · 2015 · Frontiers in Genetics
  42. De novoframeshift mutation in ASXL3 in a patient with global developmental delay, microcephaly, and craniofacial anomalies
    Darrell Lee Dinwiddie, Sarah Elizabeth Soden, Carol Saunders, Neil Miller, Emily Farrow, Laurie D. Smith, Stephen Francis Kingsmore · 2013 · BMC Medical Genomics
  43. Genes and environments in schizophrenia: The different pieces of a manifold puzzle
    János Réthelyi, Judit Benkovits, István Bitter · 2013 · Neuroscience & Biobehavioral Reviews
  44. A genomic lifespan program that reorganises the young adult brain is targeted in schizophrenia
    Nathan Skene, Marcia M. Roy, Seth G. N. Grant · 2017 · eLife
  45. DNA and RNA Cleavage Complexes and Repair Pathway for TOP3B RNA- and DNA-Protein Crosslinks
    Sourav Taru Saha, Yilun Sun, Shar-Yin Naomi Huang, Simone Andrea Baechler, Lőrinc Sándor Pongor, Keli Agama, Ukhyun Jo, Hongliang Zhang, Yuk‐Ching Tse‐Dinh, Yves G. Pommier · 2020 · Cell Reports
  46. How do established developmental risk-factors for schizophrenia change the way the brain develops?
    Darryl Walter Eyles · 2021 · Translational Psychiatry
  47. Point mutations as a source of de novo genetic disease
    Joep de Ligt, Joris A. Veltman, Lisenka E.L.M. Vissers · 2013 · Current Opinion in Genetics & Development
  48. Genetics of Complex Traits in Psychiatry
    Joel E. Gelernter · 2014 · Biological Psychiatry
  49. Integrating Multiple Genomic Data to Predict Disease-Causing Nonsynonymous Single Nucleotide Variants in Exome Sequencing Studies
    Jiaxin Wu, Yanda Li, Rui Jiang · 2014 · PLoS Genetics
  50. Topoisomerase 3β is the major topoisomerase for mRNAs and linked to neurodevelopment and mental dysfunction
    Muzammil Ahmad, Weiping Shen, Wen Li, Yutong Xue, Sige Zou, Dongyi Xu, Weidong Wang · 2016 · Nucleic Acids Research
  51. The synapse in schizophrenia
    Andrew J. Pocklington, Michael C. O’Donovan, Michael John Owen · 2014 · European Journal of Neuroscience
  52. Missense Variants in the Histone Acetyltransferase Complex Component Gene TRRAP Cause Autism and Syndromic Intellectual Disability
    Benjamin Cogné, Sophie Ehresmann, Éliane Beauregard‐Lacroix, Justine Rousseau, Thomas Besnard, Thomas Garcia, Slavé Petrovski, Shiri Avni, Kirsty M. McWalter, Patrick R. Blackburn et al. · 2019 · The American Journal of Human Genetics
  53. Type IA topoisomerases can be “magicians” for both DNA and RNA in all domains of life
    Muzammil Ahmad, Dongyi Xu, Weidong Wang · 2017 · RNA Biology
  54. A Population-Specific Uncommon Variant in GRIN3A Associated with Schizophrenia
    Atsushi Takata, Yoshimi Iwayama, Yasuhisa Fukuo, Masashi Ikeda, Tomo Okochi, Motoko Maekawa, Tomoko Toyota, Kazuo Yamada, Eiji Hattori, Tetsuo Ohnishi et al. · 2012 · Biological Psychiatry
  55. Whole-Genome Sequencing Suggests Schizophrenia Risk Mechanisms in Humans with 22q11.2 Deletion Syndrome
    Daniele Merico, Mehdi Zarrei, Gregory Costain, Lucas Ogura, Babak Alipanahi, Matthew J. Gazzellone, Nancy J. Butcher, Bhooma Thiruvahindrapuram, Thomas Nalpathamkalam, Eva W.C. Chow et al. · 2015 · G3 Genes Genomes Genetics
  56. MicroRNA Dysregulation, Gene Networks, and Risk for Schizophrenia in 22q11.2 Deletion Syndrome
    Daniele Merico, Gregory Costain, Nancy J. Butcher, W. David Warnica, Lucas Ogura, Simon E. Alfred, Linda M. Brzustowicz, Anne S. Bassett · 2014 · Frontiers in Neurology
  57. The genetic architecture of schizophrenia: review of large-scale genetic studies
    Hidekazu Kato, Hiroki Kimura, Itaru Kushima, Nagahide Takahashi, Branko Aleksić, Norio Ozaki · 2022 · Journal of Human Genetics
  58. Recent challenges to the psychiatric diagnostic nosology: a focus on the genetics and genomics of neurodevelopmental disorders
    Young Shin Kim, Matthew W. State · 2014 · International Journal of Epidemiology
  59. Increased co-expression of genes harboring the damaging de novo mutations in Chinese schizophrenic patients during prenatal development
    Qiang Wang, Miaoxin Li, Zhenxing Yang, Xun Hu, Hei-Man Wu, Peiyan Ni, Hongyan Ren, Wei Deng, Mingli Li, Xiaohong Ma et al. · 2015 · Scientific Reports
  60. Molecular Risk Factors for Schizophrenia
    Shira Modai, Noam Shomron · 2016 · Trends in Molecular Medicine
  61. Paternal Age Explains a Major Portion of De Novo Germline Mutation Rate Variability in Healthy Individuals
    Simon Girard, Cynthia V. Bourassa, Louis‐Philippe Lemieux Perreault, Marc‐André Legault, Amina Barhdadi, Amirthagowri Ambalavanan, Mara R. Brendgen, Frank Vitaro, Anne Noreau, Ginette Dionne et al. · 2016 · PLoS ONE
  62. Integrated Post-GWAS Analysis Sheds New Light on the Disease Mechanisms of Schizophrenia
    Jhih-Rong Lin, Ying Cai, Quanwei Zhang, Wen Zhang, Rubén Nogales‐Cadenas, Zhengdong D. Zhang · 2016 · Genetics
  63. Identification of de novo germline mutations and causal genes for sporadic diseases using trio‐based whole‐exome/genome sequencing
    Zi‐Bing Jin, Zhongshan Li, Zhenwei Liu, Yi Wei Jiang, Xue‐Bi Cai, Jinyu Wu · 2017 · Biological reviews/Biological reviews of the Cambridge Philosophical Society
  64. Regional Variation of Splicing QTLs in Human Brain
    Yida Zhang, Harry Taegyun Yang, Kathryn E. Kadash-Edmondson, Yang Pan, Zhicheng Pan, Beverly L. Davidson, Yi Xing · 2020 · The American Journal of Human Genetics
  65. Machine learning in schizophrenia genomics, a case‐control study using 5,090 exomes
    Yannis J Trakadis, Sameer Sardaar, Anthony Chen, Vanessa Fulginiti, Ankur Krishnan · 2018 · American Journal of Medical Genetics Part B Neuropsychiatric Genetics
  66. Expanding the neurodevelopmental phenotypes of individuals with de novo KMT2A variants
    Ada J. S. Chan, Cheryl S. Cytrynbaum, Ny Hoang, Patricia Ambrozewicz, Rosanna Weksberg, Irene Drmic, Anne M. Ritzema, Russell James Schachar, Susan Walker, Mohammed J. Uddin et al. · 2019 · npj Genomic Medicine
  67. 3q27.3 microdeletional syndrome: a recognisable clinical entity associating dysmorphic features, marfanoid habitus, intellectual disability and psychosis with mood disorder
    Julien Thévenon, Patrick Callier, Hélène Poquet, Iben Bache, Björn Menten, Valérie Malan, Maria Luigia Cavaliere, J Girod, Christel Thauvin‐Robinet, Salima El Chehadeh et al. · 2013 · Journal of Medical Genetics
  68. Temporal dynamics of miRNAs in human DLPFC and its association with miRNA dysregulation in schizophrenia
    Zhonghua Hu, Shouguo Gao, Daniel M. Lindberg, Debabrata Panja, Yoshi Wakabayashi, Keshen Li, Joel E. Kleinman, Jun Zhu, Zheng Li · 2019 · Translational Psychiatry
  69. SZDB2.0: an updated comprehensive resource for schizophrenia research
    Yong Wu, Xiaoyan Li, Jiewei Liu, Xiong‐Jian Luo, Yong‐Gang Yao · 2020 · Human Genetics
  70. Activity-Dependent Changes in Gene Expression in Schizophrenia Human-Induced Pluripotent Stem Cell Neurons
    Panos Roussos, Boris Guennewig, Dominik C. Kaczorowski, Guy Barry, Kristen Brennand · 2016 · JAMA Psychiatry
  71. Targeted Sequencing of 10,198 Samples Confirms Abnormalities in Neuronal Activity and Implicates Voltage-Gated Sodium Channels in Schizophrenia Pathogenesis
    Elliott Rees, Noa Carrera, Joanne Morgan, Kirsty Hambridge, Valentina Escott‐Price, Andrew J. Pocklington, Alexander L. Richards, Antonio F. Pardiñas, Colm McDonald, Gary J Donohoe et al. · 2018 · Biological Psychiatry
  72. Temporal, Diagnostic, and Tissue-Specific Regulation of NRG3 Isoform Expression in Human Brain Development and Affective Disorders
    Clare Paterson, Yanhong Wang, Thomas M. Hyde, Daniel R. Weinberger, Joel E. Kleinman, Amanda J. Law · 2016 · American Journal of Psychiatry
  73. An inherited duplication at the gene p21 Protein-Activated Kinase 7 (PAK7) is a risk factor for psychosis
    Morris, D. W., Pearson, R. D., Cormican, P., Kenny, E. M., O'Dushlaine, C. T., Perreault, L.-P. L., Giannoulatou, E., Tropea, D., Maher, B. S., Wormley, B. et al. · 2014 · Human Molecular Genetics
  74. Relating pathogenic loss-of-function mutations in humans to their evolutionary fitness costs
    Ipsita Agarwal, Zachary L. Fuller, Simon Myers, Molly Przeworski · 2023 · eLife
  75. Transcriptome Profiling of Peripheral Blood in 22q11.2 Deletion Syndrome Reveals Functional Pathways Related to Psychosis and Autism Spectrum Disorder
    Maria Jalbrzikowski, María T. Lázaro, Fuying Gao, Alden Huang, Carolyn C. Chow, Daniel H. Geschwind, Giovanni Coppola, Carrie E. Bearden · 2015 · PLoS ONE
  76. Formation of Chimeric Genes by Copy-Number Variation as a Mutational Mechanism in Schizophrenia
    Caitlin Rippey, Tom Walsh, Süleyman Gülsüner, Matt Brodsky, Alex S. Nord, Molly J. Gasperini, Sarah B. Pierce, Cailyn H. Spurrell, Bradley P. Coe, Niklas Krumm et al. · 2013 · The American Journal of Human Genetics
  77. Inositol pyrophosphates activate the vacuolar transport chaperone complex in yeast by disrupting a homotypic SPX domain interaction
    Joka Pipercevic, Bastian Kohl, Rūta Gerasimaitė, Véronique Comte‐Miserez, Sarah Hostachy, Thomas Müntener, Elia Agustoni, Henning Jacob Jessen, Dorothea Fiedler, Andreas Mayer et al. · 2023 · Nature Communications
  78. Functional Variants in DPYSL2 Sequence Increase Risk of Schizophrenia and Suggest a Link to mTOR Signaling
    Yaping Liu, Xuan Pham, Lilei Zhang, Pei-Lung Chen, Grzegorz M. Burzynski, David M. McGaughey, Shan He, John A. McGrath, Paula S Wolyniec, Margaret Daniele Fallin et al. · 2014 · G3 Genes Genomes Genetics
  79. Common variants in CACNA1C and MDD susceptibility: A comprehensive meta‐analysis
    Shuquan Rao, Yao Yao, Chuan Zheng, Joanne L. Ryan, Canquan Mao, Fuquan Zhang, David Meyre, Qi Xu · 2016 · American Journal of Medical Genetics Part B Neuropsychiatric Genetics
  80. Fine Mapping on Chromosome 13q32–34 and Brain Expression Analysis Implicates MYO16 in Schizophrenia
    Laura Rodriguez‐Murillo, Bin Xu, Johannes Lodewikus Roos, Gonçalo R. Abecasis, Joseph A. Gogos, Maria Karayiorgou · 2013 · Neuropsychopharmacology
  81. Deletion of TOP3B Is Associated with Cognitive Impairment and Facial Dysmorphism
    Carolyn S. Kaufman, Ann Genovese, Merlin G. Butler · 2016 · Cytogenetic and Genome Research
  82. Investigation of SHANK3 in schizophrenia
    Ana de Sena Cortabitarte, Franziska Degenhardt, Jana Strohmaier, Maren Lang, Birgit Weiß, Ralph Roeth, Ina Giegling, Stefanie Heilmann‐Heimbach, Andrea Hofmann, Dan Rujescu et al. · 2017 · American Journal of Medical Genetics Part B Neuropsychiatric Genetics
  83. De novo loss‐of‐function mutations in X‐linked SMC1A cause severe ID and therapy‐resistant epilepsy in females: expanding the phenotypic spectrum
    Sandra Jansen, Tjitske Kleefstra, Marjolein H. Willemsen, Petra de Vries, Rolph Pfundt, Jayne Y. Hehir‐Kwa, Christian Gilissen, Joris A. Veltman, Bert B A De Vries, Lisenka E.L.M. Vissers · 2016 · Clinical Genetics
  84. Progress in Genetic Studies of Tourette’s Syndrome
    Yan‐Jie Qi, Yi Zheng, Zhanjiang Li, Lan Xiong · 2017 · Brain Sciences
  85. Genetic studies of schizophrenia: an update
    Jingchun Chen, Fei Cao, Lanfen Liu, Lina Wang, Xiangning Chen · 2015 · Neuroscience Bulletin
  86. Common and Rare Genetic Risk Factors Converge in Protein Interaction Networks Underlying Schizophrenia
    Xiao Chang, Leandro de A. Lima, Yichuan Liu, Jin Li, Qingqin S. Li, Patrick M. Abou‐Sleiman, Hakon H. Hakonarson · 2018 · Frontiers in Genetics
  87. Whole-exome sequencing of 81 individuals from 27 multiply affected bipolar disorder families
    Andreas J. Forstner, Sascha B. Fischer, Lorena M. Schenk, Jana Strohmaier, Anna Maaser‐Hecker, Céline S. Reinbold, Sugirthan Sivalingam, Julian Hecker, Fabian Streit, Franziska Degenhardt et al. · 2020 · Translational Psychiatry
  88. Systematic analysis of exonic germline and postzygotic de novo mutations in bipolar disorder
    Masaki Nishioka, An‐a Kazuno, Takumi Nakamura, Naomi Sakai, Takashi Hayama, Kumiko Fujii, Koji Matsuo, Atsuko Komori, Mizuho Ishiwata, Yoshinori Watanabe et al. · 2021 · Nature Communications
  89. Topoisomerase 3β knockout mice show transcriptional and behavioural impairments associated with neurogenesis and synaptic plasticity
    Yuyoung Joo, Yutong Xue, Yue Wang, Ross A. McDevitt, Nirnath Sah, Simone Bossi, Shuaikun Su, Seung Kyu Lee, Wei Peng, Ao‐Ji Xie et al. · 2020 · Nature Communications
  90. A gradient-boosting approach for filtering de novo mutations in parent–offspring trios
    Yongzhuang Liu, Bingshan Li, Renjie Tan, Xiaolin Zhu, Yadong Wang · 2014 · Bioinformatics
  91. Structural basis of the interaction between Topoisomerase IIIβ and the TDRD3 auxiliary factor
    Sakurako Goto‐Ito, Atsushi Yamagata, Tomio S. Takahashi, Yusuke Sato, Shuya Fukai · 2017 · Scientific Reports
  92. Gene Expression in Patient-Derived Neural Progenitors Implicates WNT5A Signaling in the Etiology of Schizophrenia
    Oleg Vadimovich Evgrafov, Chris Armoskus, Bozena Wrobel, Valeria N. Spitsyna, Tade Souaiaia, Jennifer S. Herstein, Christopher Walker, Joseph Dan Khoa Nguyen, Adrian Camarena, Jonathan Weitz et al. · 2020 · Biological Psychiatry
  93. Challenges and opportunities in the investigation of unexplained intellectual disability using family‐based whole‐exome sequencing
    Céline Helsmoortel, Geert Vandeweyer, Phillip T. Ordoukhanian, Filip Van Nieuwerburgh, Nathalie Van der Aa, R. Frank Kooy · 2014 · Clinical Genetics
  94. Next‐generation sequencing in schizophrenia and other neuropsychiatric disorders
    Matthew A. Schreiber, Michael O. Dorschner, Debby W. Tsuang · 2013 · American Journal of Medical Genetics Part B Neuropsychiatric Genetics
  95. Neuropsychiatric expression and catatonia in 22q11.2 deletion syndrome: An overview and case series
    Nancy J. Butcher, Erik Boot, Anthony Edward Lang, Danielle Molinari Andrade, Jacob A. S. Vorstman, Donna M. McDonald‐McGinn, Anne S. Bassett · 2018 · American Journal of Medical Genetics Part A
  96. Genomic approaches for studying craniofacial disorders
    Kriti D. Khandelwal, Hans van Bokhoven, Tony Roscioli, Carine E.L. Carels, Huiqing Zhou · 2013 · American Journal of Medical Genetics Part C Seminars in Medical Genetics
  97. The Genetics of Neuropsychiatric Diseases: Looking In and Beyond the Exome
    Erin L. Heinzen, Benjamin M. Neale, Stephen F. Traynelis, Andrew S. Allen, David B. Goldstein · 2015 · Annual Review of Neuroscience
  98. Consensus paper of the WFSBP Task Force on Biological Markers: Criteria for biomarkers and endophenotypes of schizophrenia part II: Cognition, neuroimaging and genetics
    Andrea Schmitt, Dan Rujescu, Micha Gawlik, Alkomiet Hasan, Kenji Hashimoto, Sylvain Iceta, Marek Jarema, Joseph P. Kambeitz, Siegfried F. Kasper, Daniel Keeser et al. · 2016 · The World Journal of Biological Psychiatry
  99. Incorporating Functional Information in Tests of Excess De Novo Mutational Load
    Yu Jiang, Yujun Han, Slavé Petrovski, Kouros Owzar, David B. Goldstein, Andrew S. Allen · 2015 · The American Journal of Human Genetics
  100. Molecular dissection of germline chromothripsis in a developmental context using patient-derived iPS cells
    Sjors Middelkamp, Sebastiaan van Heesch, Arie Koen Braat, Joep de Ligt, Maarten van Iterson, Marieke Simonis, Markus J. van Roosmalen, Martijn J. E. Kelder, Evelien Kruisselbrink, Ron Hochstenbach et al. · 2017 · Genome Medicine